Nalaganje...
Levetiracetam treatment ameliorates LRRK2 pathological mutant phenotype
Mutations in leucine‐rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson's disease (PD). The LRRK2 physiological and pathological function is still debated. However, different experimental evidence based on LRRK2 cellular localization and LRRK2 protein interactors sugges...
Shranjeno v:
| izdano v: | J Cell Mol Med |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6850958/ https://ncbi.nlm.nih.gov/pubmed/31560168 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.14674 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|